Early detection and sensitive monitoring of CF lung disease: Prospects of improved and safer imaging-Reference-Cited by-同舟云学术

Early detection and sensitive monitoring of CF lung disease: Prospects of improved and safer imaging

Published:2016-09-23 Issue:S44 Volume:51 Page:S49-S60
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol.

Author:

Mall Marcus A.¹²³,Stahl Mirjam¹²³,Graeber Simon Y.¹²³,Sommerburg Olaf¹²³,Kauczor Hans-Ulrich³⁴,Wielpütz Mark O.³⁴

Affiliation:

1. Department of Translational Pulmonology; University of Heidelberg; Heidelberg Germany

2. Division of Pediatric Pulmonology and Allergy and Cystic Fibrosis Center; Department of Pediatrics; University of Heidelberg; Heidelberg Germany

3. Translational Lung Research Center Heidelberg (TLRC); Member of the German Center for Lung Research (DZL); University of Heidelberg; Heidelberg Germany

4. Department of Diagnostic and Interventional Radiology; University of Heidelberg; Heidelberg Germany

Funder

German Federal Ministry of Education and Research

German Cystic Fibrosis Association Mukoviszidose e.V.

Dietmar Hopp Foundation and the Christiane Herzog Foundation

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference85 articles.

1. Cystic fibrosis;Elborn;Lancet,2016

2. CFTR: cystic fibrosis and beyond;Mall;Eur Respir J,2014

3. Cystic fibrosis of the pancreas and its relation to celiac disease;Andersen;Am J Dis Child,1938

4. Cystic fibrosis in young children: a review of disease manifestation, progression, and response to early treatment;VanDevanter;J Cyst Fibros,2016

5. The pathogenesis of fibrocystic disease of the pancreas a study of 36 cases with special reference to the pulmonary lesions;Zuelzer;Pediatrics,1949

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or twoF508delalleles;European Respiratory Journal;2024-06-20

2. Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial;Annals of the American Thoracic Society;2023-08

3. MR imaging of the airways;The British Journal of Radiology;2023-06-01

4. TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease;Frontiers in Medicine;2023-01-06

5. Monitoring disease progression in childhood bronchiectasis;Frontiers in Pediatrics;2022-09-16